
Put company on watchlist
SARTORIUS AG
ISIN:
DE0007165631
WKN:
716563
Country: Deutschland
·
Primary market: Germany
·
EQS NID: 2127076
Levermann Score
02 May 2025 09:22AM
Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
EQS-News: SARTORIUS AG
/ Key word(s): Personnel
At today’s meeting, the Supervisory Board of Sartorius AG resolved to extend the appointment of Dr. Alexandra Gatzemeyer as a member of the Executive Board by a five-year period to April 30, 2031. Gatzemeyer, who holds a Ph.D. in chemistry and pharmacology, has been with Sartorius since 2004 and was appointed to the Executive Board in March 2023. As a board member, she is responsible for the Lab Products & Services Division.
A profile of Sartorius Sartorius is a leading international partner to life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions Division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies more safely, rapidly, and sustainably. Based in Göttingen, Germany, the company has a strong global reach with around 60 production and sales sites worldwide. Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2024, the company generated sales revenue of around 3.4 billion euros. More than 13,500 employees work for customers around the globe. Visit our Newsroom or follow us on LinkedIn. Contact Petra Kirchhoff Head of Corporate Communications & Investor Relations +49 551 308 1686 petra.kirchhoff@sartorius.com Additional features: File: Image_Alexandra Gatzemeyer_Sartorius File: 20250502_Media Release_SAG_Extension of appointment of Alexandra Gatzemeyer_EN
02.05.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
Language: | English |
Company: | SARTORIUS AG |
Otto-Brenner-Straße 20 | |
37079 Göttingen | |
Germany | |
Phone: | +49.(0)551-308.0 |
Fax: | +49.(0)551-308.3289 |
E-mail: | info@sartorius.com |
Internet: | www.sartorius.com |
ISIN: | DE0007165631, DE0007165607 |
WKN: | 716563, 716560 |
Indices: | DAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2127076 |
End of News | EQS News Service |
|
2127076 02.05.2025 CET/CEST